These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 25857454)

  • 1. The orexin 1 receptor modulates kappa opioid receptor function via a JNK-dependent mechanism.
    Robinson JD; McDonald PH
    Cell Signal; 2015 Jul; 27(7):1449-56. PubMed ID: 25857454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reactive oxygen species (ROS) generation is stimulated by κ opioid receptor activation through phosphorylated c-Jun N-terminal kinase and inhibited by p38 mitogen-activated protein kinase (MAPK) activation.
    Schattauer SS; Bedini A; Summers F; Reilly-Treat A; Andrews MM; Land BB; Chavkin C
    J Biol Chem; 2019 Nov; 294(45):16884-16896. PubMed ID: 31575661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterodimerization of human orexin receptor 1 and kappa opioid receptor promotes protein kinase A/cAMP-response element binding protein signaling via a Gαs-mediated mechanism.
    Chen J; Zhang R; Chen X; Wang C; Cai X; Liu H; Jiang Y; Liu C; Bai B
    Cell Signal; 2015 Jul; 27(7):1426-38. PubMed ID: 25866368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Kinase cascades and ligand-directed signaling at the kappa opioid receptor.
    Bruchas MR; Chavkin C
    Psychopharmacology (Berl); 2010 Jun; 210(2):137-47. PubMed ID: 20401607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of functionally selective, small molecule agonists at kappa opioid receptors.
    Zhou L; Lovell KM; Frankowski KJ; Slauson SR; Phillips AM; Streicher JM; Stahl E; Schmid CL; Hodder P; Madoux F; Cameron MD; Prisinzano TE; Aubé J; Bohn LM
    J Biol Chem; 2013 Dec; 288(51):36703-16. PubMed ID: 24187130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kappa opioid receptor activation of p38 MAPK is GRK3- and arrestin-dependent in neurons and astrocytes.
    Bruchas MR; Macey TA; Lowe JD; Chavkin C
    J Biol Chem; 2006 Jun; 281(26):18081-9. PubMed ID: 16648139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxytocin Is a Positive Allosteric Modulator of κ-Opioid Receptors but Not δ-Opioid Receptors in the G Protein Signaling Pathway.
    Miyano K; Yoshida Y; Hirayama S; Takahashi H; Ono H; Meguro Y; Manabe S; Komatsu A; Nonaka M; Mizuguchi T; Fujii H; Higami Y; Narita M; Uezono Y
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of novel functionally selective κ-opioid receptor scaffolds.
    White KL; Scopton AP; Rives ML; Bikbulatov RV; Polepally PR; Brown PJ; Kenakin T; Javitch JA; Zjawiony JK; Roth BL
    Mol Pharmacol; 2014 Jan; 85(1):83-90. PubMed ID: 24113749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structure-activity relationship studies of functionally selective kappa opioid receptor agonists that modulate ERK 1/2 phosphorylation while preserving G protein over βarrestin2 signaling bias.
    Lovell KM; Frankowski KJ; Stahl EL; Slauson SR; Yoo E; Prisinzano TE; Aubé J; Bohn LM
    ACS Chem Neurosci; 2015 Aug; 6(8):1411-9. PubMed ID: 25891774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional selectivity of 6'-guanidinonaltrindole (6'-GNTI) at κ-opioid receptors in striatal neurons.
    Schmid CL; Streicher JM; Groer CE; Munro TA; Zhou L; Bohn LM
    J Biol Chem; 2013 Aug; 288(31):22387-98. PubMed ID: 23775075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterodimerization of the kappa opioid receptor and neurotensin receptor 1 contributes to a novel β-arrestin-2-biased pathway.
    Liu H; Tian Y; Ji B; Lu H; Xin Q; Jiang Y; Ding L; Zhang J; Chen J; Bai B
    Biochim Biophys Acta; 2016 Nov; 1863(11):2719-2738. PubMed ID: 27523794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen Regulation of GRK2 Inactivates Kappa Opioid Receptor Signaling Mediating Analgesia, But Not Aversion.
    Abraham AD; Schattauer SS; Reichard KL; Cohen JH; Fontaine HM; Song AJ; Johnson SD; Land BB; Chavkin C
    J Neurosci; 2018 Sep; 38(37):8031-8043. PubMed ID: 30076211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stress-induced p38 mitogen-activated protein kinase activation mediates kappa-opioid-dependent dysphoria.
    Bruchas MR; Land BB; Aita M; Xu M; Barot SK; Li S; Chavkin C
    J Neurosci; 2007 Oct; 27(43):11614-23. PubMed ID: 17959804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. U50,488H-induced internalization of the human kappa opioid receptor involves a beta-arrestin- and dynamin-dependent mechanism. Kappa receptor internalization is not required for mitogen-activated protein kinase activation.
    Li JG; Luo LY; Krupnick JG; Benovic JL; Liu-Chen LY
    J Biol Chem; 1999 Apr; 274(17):12087-94. PubMed ID: 10207034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visualizing differences in ligand-induced beta-arrestin-GFP interactions and trafficking between three recently characterized G protein-coupled receptors.
    Evans NA; Groarke DA; Warrack J; Greenwood CJ; Dodgson K; Milligan G; Wilson S
    J Neurochem; 2001 Apr; 77(2):476-85. PubMed ID: 11299310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular Interaction Between Butorphanol and κ-Opioid Receptor.
    Ji J; Lin W; Vrudhula A; Xi J; Yeliseev A; Grothusen JR; Bu W; Liu R
    Anesth Analg; 2020 Sep; 131(3):935-942. PubMed ID: 32701545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Agonist-dependent desensitization of the kappa opioid receptor by G protein receptor kinase and beta-arrestin.
    Appleyard SM; Celver J; Pineda V; Kovoor A; Wayman GA; Chavkin C
    J Biol Chem; 1999 Aug; 274(34):23802-7. PubMed ID: 10446141
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signaling Properties of Structurally Diverse Kappa Opioid Receptor Ligands: Toward in Vitro Models of in Vivo Responses.
    Dunn AD; Reed B; Erazo J; Ben-Ezra A; Kreek MJ
    ACS Chem Neurosci; 2019 Aug; 10(8):3590-3600. PubMed ID: 31313902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nalfurafine is a G-protein biased agonist having significantly greater bias at the human than rodent form of the kappa opioid receptor.
    Schattauer SS; Kuhar JR; Song A; Chavkin C
    Cell Signal; 2017 Apr; 32():59-65. PubMed ID: 28088389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of RGS12 in the differential regulation of kappa opioid receptor-dependent signaling and behavior.
    Gross JD; Kaski SW; Schmidt KT; Cogan ES; Boyt KM; Wix K; Schroer AB; McElligott ZA; Siderovski DP; Setola V
    Neuropsychopharmacology; 2019 Sep; 44(10):1728-1741. PubMed ID: 31141817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.